Vanguard Group Inc A Ikido Pharma Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 188,929 shares of AIKI stock, worth $717,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188,929
Previous 193,392
2.31%
Holding current value
$717,930
Previous $734,000
2.32%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AIKI
# of Institutions
22Shares Held
790KCall Options Held
0Put Options Held
0-
Pfg Investments, LLC Woodbury, NY142KShares$537,7300.04% of portfolio
-
Exodus Point Capital Management, LP New York, NY110KShares$418,0000.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA64.4KShares$244,7840.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny52.3KShares$198,6030.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...